FOR IMMEDIATE RELEASE Portland, Maine — January 31, 2019 – Those dealing with sarcoma know that resources and support can be difficult to find. Members of the newly formed Sarcoma [...]
The American Association for Cancer Research (AACR) issued the following press release focused on the Angiosarcoma Project, whose work is guided by Angiosarcoma Awareness, Inc.’s Vice President Dr. Corrie Painter. [...]
A new Phase II clinical trial targeting angiosarcoma is now recruiting patients at Boston’s Massachusetts General Hospital and the Dana-Farber Cancer Institute. For details on this and other available trials, [...]
After taking a year off for a strategic re-brand, we are excited to unveil the return of our community’s beloved 5K event, revamped for its 7th year, in its new [...]
Because angiosarcoma is an exceedingly rare cancer, it has never been the focus of large scale scientific endeavors. However, patients are now able to participate in two research projects aimed [...]
We are pleased to announce that Angiosarcoma Awareness, Inc. has entered into a unique year-long collaboration with a fellow rare cancer advocacy organization, TargetCancer Foundation (TCF). This partnership will leverage the strengths of our respective organizations towards [...]
“I knew I was making progress when Tory said to me, ‘I forgot I had cancer for an entire day’ with happy tears rolling down her cheeks. My heart was [...]
Please help us spread the word about the Angiosarcoma Project, which was recently launched as a collaboration between the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute. [...]
